 |
Adam Bonislawski is the editor of GenomeWeb's ProteoMonitor. He covers proteomics and life science mass spectrometry. E-mail Adam Bonislawski and follow his GenomeWeb Twitter account at @ProteoMonitor. |
Verisante Highlights Data Backing Lung Cancer Dx, Preps Skin Cancer Dx for Year-End Launch
November 30, 2012
Verisante Highlights Data Backing Lung Cancer Dx, Preps Skin Cancer Dx for Year-End Launch
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- Verisante This Year to Launch Point-of-Care Biomarker-Based Skin Cancer Test
March 4, 2011 / ProteoMonitor - GenomeWeb Feature: The Unsteady March of Cancer Protein Biomarkers into the Clinic
May 10, 2013 / ProteoMonitor - Verisante Notches First Sales of Aura Skin Cancer Detection Device
February 1, 2013 / ProteoMonitor - Biodesix Inks Deal to Test Veristrat in Phase III Clinical Trial for Kadmon Lung Cancer Drug
March 2, 2012 / ProteoMonitor - Theranostics Health to Launch HER Signaling Assay, Marking Firm's First Commercial Test Release
May 3, 2013 / ProteoMonitor